Value of CT-PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinoma.
about
Understanding Complete Pathologic Response in Oesophageal Cancer: Implications for Management and SurvivalPhase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal CancerThe value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma.Radiotherapy response evaluation using FDG PET-CT-established and emerging applications.Effectiveness of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Computerized Tomography (PET-CT) Scan in Identifying Interval Metastases for Patients with Esophageal Cancer.Impact of number of [(18)F]fluorodeoxyglucose-PET-positive lymph nodes on survival of patients receiving neoadjuvant chemotherapy and surgery for oesophageal cancer.Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial.Active surveillance in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal or junctional cancer.Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma.Personalized therapy based on image for esophageal or gastroesophageal junction adenocarcinoma.18F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma.Restaging oesophageal cancer after neoadjuvant therapy with (18)F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery.Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy.
P2860
Q26798220-995F40C9-3316-4518-9FF4-379A380FF882Q33434339-29F083A6-6C99-4771-B3F6-FC7EFE691DA7Q37433616-D773DFE4-9308-40E4-86B5-EEAAEACBBFA2Q39051286-86BFE281-0727-44EF-B27E-F8AE69E43B81Q39069534-44BC9666-DDB0-4C49-ADC1-D11ED9EC0655Q41180800-ABC28BB8-9891-4F78-B8AE-ABE9DEC4A293Q47346404-CAE65AED-211D-44E4-B312-A47237D21685Q47960613-C7734BD3-ED7B-4BF0-A3C8-7AD8DB39A222Q50635875-1772FF6F-5889-4E8F-A9E3-DB8E3510EEDAQ52581750-C27DBCD8-00EE-4CD5-8D2F-D0662FB7E479Q52942088-63A8F636-A5E8-4321-99CC-CE81A9D4FD77Q52984885-F5CC6751-CA04-445F-9049-BA2E01A2A740Q55437617-6A5FA503-EFD0-4CEA-86EF-E83CE486D13E
P2860
Value of CT-PET after neoadjuvant chemoradiation in the prediction of histological tumour regression, nodal status and survival in oesophageal adenocarcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Value of CT-PET after neoadjuv ...... in oesophageal adenocarcinoma.
@en
Value of CT-PET after neoadjuv ...... in oesophageal adenocarcinoma.
@nl
type
label
Value of CT-PET after neoadjuv ...... in oesophageal adenocarcinoma.
@en
Value of CT-PET after neoadjuv ...... in oesophageal adenocarcinoma.
@nl
prefLabel
Value of CT-PET after neoadjuv ...... in oesophageal adenocarcinoma.
@en
Value of CT-PET after neoadjuv ...... in oesophageal adenocarcinoma.
@nl
P2093
P2860
P356
P1476
Value of CT-PET after neoadjuv ...... in oesophageal adenocarcinoma
@en
P2093
C Johnston
D Halpenny
J V Reynolds
N J O'Farrell
P2860
P304
P356
10.1002/BJS.9670
P407
P577
2014-10-28T00:00:00Z